Elicityl
PrivateLast Round
VC Round
Sep 27, 2015
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Elicityl is a biotechnology company that specializes in the design, manufacturing, and supply of bioactive oligosaccharides, polysaccharides, and glycoconjugates for applications in human health, animal nutrition, and plant health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elicityl Comparables
Compare Elicityl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sussex Research Laboratories Inc. | 84% | |
| zuChem, Inc. | 84% | |
| ICE Pharma | 79% |
Elicityl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 27, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 50% MoM, from 1.3K to 2K.
- Apr 9, 2026
Monthly visitors grew 69% MoM, reaching 3.9K.
Elicityl Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elicityl's valuation, stock price, and market status.
Is Elicityl a public or private company?
Elicityl is a private company.
What is the current stock price of Elicityl?
Elicityl is a private company, so its shares have no public market price. Caplight tracks Elicityl's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elicityl worth (valuation)?
Valuation information for Elicityl is not publicly available.
Can I buy Elicityl stock?
Elicityl shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elicityl's last funding round?
Elicityl's most recent funding round was VC Round on September 27, 2015.
Who are the main investors in Elicityl?
Investor information for Elicityl is not publicly disclosed.
Will Elicityl IPO soon?
No public IPO plans have been announced for Elicityl.
How can I track Elicityl secondary market activity?
Caplight tracks bids, offers, and trades in Elicityl's shares on secondary markets.